Status:
UNKNOWN
The Predictive and Diagnostic Value of Cystatin C and High Sensitive Troponin
Lead Sponsor:
Ankara Diskapi Training and Research Hospital
Conditions:
Acute Coronary Syndrome
Chronic Kidney Diseases
Eligibility:
All Genders
18+ years
Brief Summary
Our study is planning to evaluate patients with chronic kidney disease who come to the emergency department with chest pain. Estimated GFR (cisGFR) with cystatin and estimated GFR (creaGFR) with creat...
Detailed Description
Our study is planning to evaluate patients with chronic kidney disease who come to the emergency department with chest pain. Estimated GFR (cisGFR) with cystatin and estimated GFR (creaGFR) with creat...
Eligibility Criteria
Inclusion
- Age over 18,
- chronic kidney diease having chest pain or equivalent of chest pain (dyspnea, diaphoresis, syncope, nausea, vomiting) -
Exclusion
- STEMI,
- age less than 18,
- missing data,
- patients referred to or accepted from another medical facility
Key Trial Info
Start Date :
March 7 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT05303441
Start Date
March 7 2022
End Date
February 1 2023
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diskapi Research and Training Hospital
Ankara, Turkey (Türkiye), 06110